pregnancy and glp 1 Glucagon-like peptide-1 receptor agonist use in pregnancy: a review GLP-1 use during early pregnancy

Commun Biol 7 , 843 (2024)

Notably, exenatide has demonstrated the ability to reduce intracranial pressure without significant changes in body weight, presenting a novel therapeutic approach for managing headaches linked to intracranial hypertension [99]

The uptick in NAION-related lawsuits follows the publication of a June 2025 study in JAMA Ophthalmology , which found a significant association between semaglutide use and increased risk of optic nerve damage

Movement and physical activity should be incorporated throughout the day to improve our immune system ability to fight infections by increasing the number of white blood cells and antibodies, and by increasing blood circulation